HomeTBPH • NASDAQ
Theravance Biopharma Inc
add
$14.47
2.99%
After Hours:(1.17%)-0.17
$14.30
Closed: Sep 18, 5:44:03 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 26.20M | 83.75% |
Operating expense | 18.43M | 8.06% |
Net income | 54.84M | 431.75% |
Net profit margin | 209.33 | 280.55% |
Earnings per share | -0.08 | 35.23% |
EBITDA | -2.32M | 81.21% |
Effective tax rate | 25.09% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 338.80M | 252.63% |
Total assets | 426.04M | 17.68% |
Total liabilities | 201.19M | 19.51% |
Total equity | 224.85M | — |
Shares outstanding | 50.36M | — |
Price to book | 3.15 | — |
Return on assets | -1.77% | — |
Return on capital | -2.81% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 54.84M | 431.75% |
Cash from operations | 208.07M | 4,812.89% |
Cash from investing | -36.26M | -1,096.24% |
Cash from financing | -503.00K | -1,043.18% |
Net change in cash | 171.31M | 2,387.22% |
Free cash flow | 18.70M | 2,419.57% |
Previous close
$14.05
Day range
$13.99 - $14.50
Year range
$7.88 - $14.55
Market cap
728.73M USD
Avg Volume
534.72K
P/E ratio
61.83
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2013
Website
Employees
97
